These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1936 related articles for article (PubMed ID: 26220361)
1. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation. Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361 [TBL] [Abstract][Full Text] [Related]
2. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Wensveen FM; Jelenčić V; Valentić S; Šestan M; Wensveen TT; Theurich S; Glasner A; Mendrila D; Štimac D; Wunderlich FT; Brüning JC; Mandelboim O; Polić B Nat Immunol; 2015 Apr; 16(4):376-85. PubMed ID: 25729921 [TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Kintscher U; Hartge M; Hess K; Foryst-Ludwig A; Clemenz M; Wabitsch M; Fischer-Posovszky P; Barth TF; Dragun D; Skurk T; Hauner H; Blüher M; Unger T; Wolf AM; Knippschild U; Hombach V; Marx N Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1304-10. PubMed ID: 18420999 [TBL] [Abstract][Full Text] [Related]
4. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Harford KA; Reynolds CM; McGillicuddy FC; Roche HM Proc Nutr Soc; 2011 Nov; 70(4):408-17. PubMed ID: 21835098 [TBL] [Abstract][Full Text] [Related]
5. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first? Bouloumié A; Casteilla L; Lafontan M Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1211-3. PubMed ID: 18565843 [No Abstract] [Full Text] [Related]
7. Adipose tissue macrophages do not affect atherosclerosis development in mice. Bijnen M; van de Gaar J; Vroomen M; Gijbels MJ; de Winther M; Schalkwijk CG; Wouters K Atherosclerosis; 2019 Feb; 281():31-37. PubMed ID: 30654169 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Lee BC; Lee J Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515 [TBL] [Abstract][Full Text] [Related]
10. Perforin is a novel immune regulator of obesity-related insulin resistance. Revelo XS; Tsai S; Lei H; Luck H; Ghazarian M; Tsui H; Shi SY; Schroer S; Luk CT; Lin GH; Mak TW; Woo M; Winer S; Winer DA Diabetes; 2015 Jan; 64(1):90-103. PubMed ID: 25048196 [TBL] [Abstract][Full Text] [Related]
11. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Verboven K; Wouters K; Gaens K; Hansen D; Bijnen M; Wetzels S; Stehouwer CD; Goossens GH; Schalkwijk CG; Blaak EE; Jocken JW Sci Rep; 2018 Mar; 8(1):4677. PubMed ID: 29549282 [TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216 [TBL] [Abstract][Full Text] [Related]
13. Regulation, Communication, and Functional Roles of Adipose Tissue-Resident CD4 Zhou H; Liu F Front Immunol; 2018; 9():1961. PubMed ID: 30233575 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance. Ye L; Liang S; Guo C; Yu X; Zhao J; Zhang H; Shang W Life Sci; 2016 Dec; 166():82-91. PubMed ID: 27702567 [TBL] [Abstract][Full Text] [Related]
15. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Zeyda M; Farmer D; Todoric J; Aszmann O; Speiser M; Györi G; Zlabinger GJ; Stulnig TM Int J Obes (Lond); 2007 Sep; 31(9):1420-8. PubMed ID: 17593905 [TBL] [Abstract][Full Text] [Related]
16. Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice. O'Rourke RW; White AE; Metcalf MD; Winters BR; Diggs BS; Zhu X; Marks DL Metabolism; 2012 Aug; 61(8):1152-61. PubMed ID: 22386937 [TBL] [Abstract][Full Text] [Related]
17. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579 [TBL] [Abstract][Full Text] [Related]
18. IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance. Han JM; Wu D; Denroche HC; Yao Y; Verchere CB; Levings MK J Immunol; 2015 May; 194(10):4777-83. PubMed ID: 25870243 [TBL] [Abstract][Full Text] [Related]
19. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance. Finucane OM; Reynolds CM; McGillicuddy FC; Roche HM Proc Nutr Soc; 2012 Nov; 71(4):622-33. PubMed ID: 22914223 [TBL] [Abstract][Full Text] [Related]
20. IL-37 protects against obesity-induced inflammation and insulin resistance. Ballak DB; van Diepen JA; Moschen AR; Jansen HJ; Hijmans A; Groenhof GJ; Leenders F; Bufler P; Boekschoten MV; Müller M; Kersten S; Li S; Kim S; Eini H; Lewis EC; Joosten LA; Tilg H; Netea MG; Tack CJ; Dinarello CA; Stienstra R Nat Commun; 2014 Sep; 5():4711. PubMed ID: 25182023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]